44.09

1.08% 0.47

Pre-market: 44.50 0.41 +0.93%

Amphastar Pharmaceuticals Inc (AMPH)

Overview News Price History Option Chain Financials Why AMPH Down? Discussions Forecast

Amphastar Pharmaceuticals Inc stock is traded at $44.09, with a volume of 599.68K. It is up +1.08% in the last 24 hours and down -13.28% over the past month. Amphastar Pharmaceuticals Inc is a biopharmaceutical company that focuses on developing, manufacturing, marketing, and selling technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the company sells insulin API products. The company's finished products are used in hospital or urgent care clinical settings and are contracted and distributed through group purchasing organizations and drug wholesalers. The company has two reportable segments finished pharmaceutical products and API products. Geographically the business presence of the firm is seen in the United States, China and France of which the U.S. accounts for the majority of the revenue.

Previous Close:

$43.62

Open:

$43.71

24h Volume:

599.68K

Relative Volume:

1.75

Market Cap:

$2.13B

Revenue:

$712.89M

Net Income/Loss:

$166.52M

P/E Ratio:

22.61

EPS:

1.95

Net Cash Flow:

$178.13M

1W Performance:

-3.06%

1M Performance:

-13.28%

6M Performance:

+2.37%

1Y Performance:

-22.09%

1-Day Range:

$43.09

$44.54

1-Week Range:

$43.09

$45.91

52-Week Range:

$36.56

$65.92

Amphastar Pharmaceuticals Inc Stock (AMPH) Company Profile

Name

Amphastar Pharmaceuticals Inc

Sector

Healthcare (1193)

Industry

Drug Manufacturers - Specialty & Generic (87)

Phone

909-980-9484

Address

11570 SIXTH STREET, RANCHO CUCAMONGA, CA

Employee

1,761

Twitter

Next Earnings Date

2024-12-06

Latest SEC Filings

AMPH's Discussions on Twitter

Compare AMPH with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
AMPH	44.09	2.13B	712.89M	166.52M	178.13M	1.95
ZTS	175.67	78.47B	9.15B	2.43B	2.31B	4.92
HLN	9.48	42.84B	14.26B	1.55B	0	0.3327
TAK	13.29	42.13B	30.27B	1.93B	3.45B	0.444
TEVA	17.03	19.19B	16.77B	-959.00M	1.37B	-2.00
VTRS	13.13	15.67B	15.24B	-646.50M	1.88B	1.53

Amphastar Pharmaceuticals Inc Stock (AMPH) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Nov-17-23	Initiated	BofA Securities	Neutral
Jul-25-23	Resumed	Jefferies	Buy
Oct-21-22	Resumed	Jefferies	Buy
Jul-29-22	Initiated	CapitalOne	Overweight
Jan-07-22	Upgrade	Piper Sandler	Neutral → Overweight
Jan-08-21	Downgrade	Wells Fargo	Overweight → Equal Weight
Oct-05-20	Upgrade	Northland Capital	Market Perform → Outperform
May-01-20	Initiated	Northland Capital	Outperform
Mar-13-19	Downgrade	Needham	Buy → Hold
Mar-13-19	Downgrade	Piper Jaffray	Overweight → Neutral
Aug-10-18	Reiterated	Needham	Buy
Mar-13-18	Reiterated	Needham	Buy
Dec-01-17	Reiterated	Needham	Buy
Nov-09-17	Downgrade	Raymond James	Outperform → Mkt Perform
Sep-27-17	Reiterated	Needham	Buy
Mar-14-17	Downgrade	Raymond James	Strong Buy → Outperform
Aug-09-16	Reiterated	Needham	Buy
May-10-16	Reiterated	Needham	Buy
Feb-19-16	Initiated	Wells Fargo	Outperform
Jun-19-15	Reiterated	Needham	Buy
Jun-03-15	Initiated	Raymond James	Strong Buy
Jul-21-14	Initiated	Needham	Buy

View All

Amphastar Pharmaceuticals Inc Stock (AMPH) Latest News

Nov 19, 2024

Injectables Contraceptives Market with Promising Opportunity - openPR

Nov 19, 2024

Principal Financial Group Inc. Has $9.80 Million Stock Holdings in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - MarketBeat

Nov 19, 2024

Principal Financial Group Inc. Cuts Stake in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) - Defense World

Nov 19, 2024

Nov 16, 2024

16,169 Shares in Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) Purchased by Los Angeles Capital Management LLC - MarketBeat

Nov 16, 2024

Nov 13, 2024

Amphastar Pharmaceuticals executive sells $336,929 in stock - Investing.com

Nov 13, 2024

Amphastar Pharmaceuticals director Richard Prins sells $243,985 in stock - Investing.com India

Nov 13, 2024

Amphastar Pharmaceuticals to Present at the Jefferies London Healthcare Conference - AccessWire

Nov 13, 2024

Amphastar Pharmaceuticals to Present at Jefferies London Healthcare Conference | AMPH Stock News - StockTitan

Nov 13, 2024